PERLMAN ANDREW J 4
4 · Arcus Biosciences, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
PERLMAN ANDREW J
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-14+16,800→ 16,800 totalExercise: $20.62Exp: 2032-06-13→ Common Stock (16,800 underlying) - Award
Common Stock
2022-06-14+4,100→ 11,125 total
Footnotes (3)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]Includes 1,500 and 3,000 shares of restricted stock units (previously reported) that vested on December 15, 2021 and June 3, 2022, respectively.
- [F3]The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.